Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Osteosarcoma 2Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Neoplasm Metastasis 1Breast Neoplasms 1

Interventions

Doxorubicin 15pembrolizumab 12Surgical Procedures, Operative 8Cyclophosphamide 8Blood Specimen Collection 8Ifosfamide 7Gemcitabine 7Surveys and Questionnaires 6Nivolumab 6Trabectedin 5Radiotherapy 5Magnetic Resonance Spectroscopy 5Drug Therapy 5atezolizumab 4Temozolomide 4Specimen Handling 4Radiation Dose Hypofractionation 4Biopsy 4pazopanib 3liposomal doxorubicin 3fludarabine 3cabozantinib 3anlotinib 3Radiation 3Observation 3Docetaxel 3Dacarbazine 3trastuzumab deruxtecan 2toripalimab 2selinexor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Sarcoma × Disulfiram × Clear all
NCT05210374 2026-06-05

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

Case Comprehensive Cancer Center

Phase 1 Recruiting
24 enrolled
Sarcoma

Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡